Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -3.31% | 5.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.97% | -21.17% | |||
| Operating Income | -0.97% | 21.17% | |||
| Income Before Tax | 1.63% | 21.66% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.63% | 21.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.63% | 21.66% | |||
| EBIT | -0.97% | 21.17% | |||
| EBITDA | -1.01% | 21.24% | |||
| EPS Basic | 11.93% | 22.62% | |||
| Normalized Basic EPS | 11.85% | 22.65% | |||
| EPS Diluted | 11.93% | 22.62% | |||
| Normalized Diluted EPS | 11.85% | 22.65% | |||
| Average Basic Shares Outstanding | 11.65% | 1.24% | |||
| Average Diluted Shares Outstanding | 11.65% | 1.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||